TrialBMC cancer2020

Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results.

Makoto Ueno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.